News
Swiss Deep Tech News & Analysis
Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.
Curated Newsfeed
-
Amazon acquires robotics start-up RIVR
startupticker.ch
-
Ecorobotix: 1,000 ARA ultra-high-precision sprayers sold worldwide
startupticker.ch
-
SwissBorg secures MiCA approval from French AMF
startupticker.ch
-
Fintech company Axiym receives strategic investment from Tether
startupticker.ch
DTN Highlights
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global EconomyThe technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor LayerSwiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space SummitESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of ScaleIn Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Read more: SICTIC: Backed to the FutureThomas Dübendorfer doesn’t invest like a portfolio manager optimizing for returns. He invests like a scout who found someone worth running alongside – and then…
-
Read more: SICTIC: At Face ValueThe Very First Cheque When you ask investors at what point in their careers they wrote their first cheque, most will probably tell you a…
-
Read more: “Kick Ass Globally”: Inside Project Switzerland’s First Community GatheringOn April 30, 2026, the country’s most accomplished tech founders and the ten Scale-ups selected for the inaugural Project Switzerland cohort sat down together for…
-
Read more: AI in Switzerland: Stanford Data Confirms World Leading Talent DensityThe Stanford AI Index Report 2026, released in April 2026, ranks Switzerland first in the world for AI researchers and inventors per capita, with 110.5…
-
Read more: Swiss-Built Precision Powers NASA’s Return to the MoonOn April 1, 2026, NASA’s Artemis II mission launched four astronauts toward the Moon, marking the first crewed flight beyond low Earth orbit since 1972.…
-
CHF 39 million for BE WTR eco-friendly premium water solutions
BE WTR, the Swiss startup revolutionizing sustainable water solutions, just closed its CHF 39M Series C funding round. This new round of funding will accelerate BE…
startupticker.ch
startupticker.ch: CHF 39 million for BE WTR eco-friendly premium water solutions- BE WTR closed a CHF 39M Series C round led by Convent Capital to expand sustainable water solutions globally.
- The company operates compact on-site bottling plants in high-end venues, targeting over 20 locations by end-2025.
- BE WTR offers water activation and circular bottling as a sustainable alternative to traditional bottled water.
-
Lymphatica Medical raises €17.9 million in series B Funding
Lymphatica Medtech SA is a clinical-stage company based in Lausanne, specialized in innovative treatments for lymphedema, a chronic vascular condition that currently has no cure…
startupticker.ch
startupticker.ch: Lymphatica Medical raises €17.9 million in series B Funding- Lymphatica Medtech raised Series B funding to advance LymphoDrain, an implantable device for treating lymphedema.
- LymphoDrain is minimally invasive, implanted subcutaneously, and actively restores lymphatic vessel function.
- Dan Rose, former leader at LimFlow and Medtronic, joined as Chairman, strengthening the board.
-
€36 million to digitalise farming with xFarm’s platform
xFarm Technologies a Swiss-Italian startup dedicated to digitalising the agri-food sector, has raised €36 million in series C round. The funds will enable the company…
startupticker.ch
startupticker.ch: €36 million to digitalise farming with xFarm’s platform- xFarm supports 450,000+ farms across 100+ supply chains covering 7 million hectares using AI-powered data analysis and regenerative agriculture models.
- xFarm is creating a new Fintech and Insurtech division to enhance insurance and financial management services for farmers.
-
CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial
Somagenetix AG, a pioneering biotech company focussing on gene therapies for disorders affecting a type of white blood cells, raised CHF 10 million in a…
startupticker.ch
startupticker.ch: CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial- Somagenetix AG raised CHF 10M in Series A funding for SGX-001, a gene therapy for p47 Chronic Granulomatous Disease, targeting 2026 clinical trials.
- The company's lentiviral gene therapy platform offers a one-time treatment alternative to stem cell transplants for inherited immunodeficiencies.
- Dr. Andrin Oswald joined as CEO, bringing over 20 years of pharmaceutical leadership experience to guide clinical development.
-
FDA approvals and clinical advancements propel life sciences startups forward
Four startups are making strides in developing novel solutions for challenging medical conditions, potentially offering new hope for patients. Alentis Therapeutics and Abionic have received…
startupticker.ch
startupticker.ch: FDA approvals and clinical advancements propel life sciences startups forward- Alentis Therapeutics received FDA clearance for ALE.P02, an antibody-drug conjugate for CLDN1+ squamous cancers, with Phase 1/2 trials starting Q1 2025.
- Abionic's CAPSULE PSP test gained FDA approval for rapid sepsis detection in blood samples within five minutes, improving patient outcomes.
- Anokion's ANK-700 showed clinical proof of concept for treating relapsing-remitting multiple sclerosis by re-educating immune tolerance to myelin.
-
Voliro secures $12M in Series A funding to transform industrial inspections with drones
Voliro, a leading innovator in aerial mobile robotics, closed a $12 million in Series A funding round led by Cherry Ventures. The new funding will…
startupticker.ch
startupticker.ch: Voliro secures $12M in Series A funding to transform industrial inspections with drones- Voliro raised $12 million in Series A funding to expand aerial robotics for industrial inspection, maintenance, and repair work.
- Voliro's tiltable rotor drones enable non-destructive testing and contact-based inspections on hard-to-reach infrastructure.
- Voliro offers a B2B subscription model including hardware, software, training, support, and updates for customers.
-
Read more: Switzerland, Big Pharma’s Shopping CentreThe top pharmaceutical companies are very active in Switzerland, participating in large financing rounds and acquiring companies or drug candidates. In 2024, the global number…
-
Read more: Robots and the Swiss Tradition of Customer FocusFor Swiss robotics startups, customer success and investor success go hand in hand. In addition to outstanding technology, this requires a high degree of customer…
